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Old age is not a disease - it is strength and survivorship, triumph over all kinds 
of vicissitudes and disappointments, trials and illnesses.  










In many societies the population is getting older, such that in some western countries 
it is expected that those over 80 years of age will make up 30% of the population (1-
2). In the modern era, due to improved health and better medical support/treatment, 
many people may spend as many years retired as they did working. Unfortunately, 
as one ages, the burden of disease increases (2.9 million people in England have >1 
long-term condition), longevity is compromised by disability; therefore the drive must 
be to add life to years rather than just years to life. When people live long, the media 
often asks “what is the success associated with longevity or successful (healthy) 
ageing?”  Is it a success to live a long life, or is successful ageing the key? Healthy 
ageing, is defined as a state, where the effect of frailty, sarcopenia, disease and 
disability have been minimised. Farpour et al (3) discuss the effect that aging has on 
Iranian people, and Liang et al discuss the findings of a systematic review looking at 
traditional Chinese’ medicine and subhealth (4), which could be aligned to prefrailty.   
 
In 2015 the WHO defined Health as “a state of complex physical, mental and social 
well-being and not merely absence of disease” (5). Healthy ageing was also defined 
as “the process of developing and maintaining the functional ability that enables well-
being in older age”. Rowe and Khan (1987) commented that to age successfully one 
must avoid disease, remain engaged with life and maintain a high level of physical 
and cognitive function (6). Healthy ageing is, therefore, a complex interplay between 
physical, cognitive and social factors, and perhaps is dependent on how we 
individually respond to the internal and external forces at play (table 1).  
 
The definition of what is normal and what is abnormal is fraught with difficulty; what 
is acceptable and what is not? There is a risk that where normative parameters (for 
younger adults) are exceeded there will be a medicalisation of “older age”!  
 
What ultimately matters is the preservation of functional ability, which the majority 
(75%) of very old people are able to do and live relatively independent lives (6). This 
paper will discuss the interdependency between healthy ageing, appetite, frailty and 
sarcopenia and their impact on functional ability. 
 
Ageing  
Ageing is a life-long process and not a disease. In western countries the onset of old 
age has been the age of retirement and access to a pension. If the onset of old age 
is taken at the age of 65 years, then this third age can be divided into the young (65-
74), old (75-85) and very old (‘old-old’; 85+). It is projected that, by 2041, two thirds 
of the population will be older than 70 years (1, 2) and by 2050, 20% of the world’s 
population of 2 billion will be >65 years (1.2 x 1011). Those > 80 years are set to 
increase by 300% and centenarians 15 fold (3). Generally, within these age groups 
women are predominant, particularly in the old-old. Chronological age marches 
relentlessly onward unless interrupted by sudden death (eg trauma or cancer). The 
velocity of biological ageing is influenced by both internal (genetics) and external 
factors (smoking, poor diet, pollution, illicit drugs, alcohol; seeTable 1).    
 
However, one must ask; when does one become ‘old’? Today, who is old and what 
determines old age depends on the society and culture in which we live. Old, on the 
whole, is often simply older than oneself!  Age is a number determined from the year 
of birth, and at birth age is either one or zero depending on Eastern or Western 
culture. In other cultures, age may be determined by significant events in the 
calendar, such as seasons or momentous events. 
 
As society and its members age, Society is engrossed with age, or rather with 
delaying the inevitable. Money and time are spent undergoing surgery or buying 
creams to hide the appearance of wrinkles (7), tell-tale signs of getting older.  
 
Energy requirement, appetite and efficiency 
With increasing age, there is a reduction in physical activity, energy requirement, 
appetite regulation and energy efficiency. As age increases people eat and drink less 
and what they do eat is not efficiently converted to energy and utilised. Frailty 
intervenes when there is a decline in physical function due to changes at the 
molecular and cellular level, particularly in the musculoskeletal system.  
 
Energy Requirements 
Physical activity decreases between the ages of 20 and 80 years. At the same time, 
there is an increase in coexistent chronic disease, a reduction in basal metabolic rate 
(BMR; 2% each decade, from the age of 20 years) and a dysregulation of appetite 
(8,9). As a consequence, there is a linear decline in energy requirements of 165 
kcal/decade in men and 103 kcal/decade in women to approximately 2000 kcal/day 
or less (10,11). Energy intake is markedly variable (20-25% variability) coupled with 
only a 10% variability in energy expenditure (12). This imbalance, results in a 
general weight loss of up to 0.65kg/year. Weight regulation is further affected in that 
the ability to return to the previous body weight following gain (or loss) is markedly 
impaired (13). When the body is under extra stress, and extra energy is required, the 
body may be unable to utilise the body’s energy sources efficiently (eg through 
mitochondrial down-regulation). The imbalance between energy intake and 
expenditure, coupled with inefficient energy use, results in fatigue and tiredness. 
 
 
Nutrition and hydration 
With frailty, not only is there a reduction in food and fluid intake and energy 
efficiency, but additionally the type of food eaten by frail older people may be 
different to that of younger people. Changes to diet are often driven, in part by food 
cost, availability and accessibility in older age. Declining numbers of teeth, use (or 
not) of dentures, age-related changes to taste and smell, a reduction in the number 
of taste buds/ papillae in the tongue (which leads to a relative preponderance of 
bitter and sweet receptors) all contribute to changes in diet. In many instances food 
can taste bland, such that strong flavours (14) are preferred.  
 
Societies, particularly in the west are besotted with diets both to lose weight and 
prolong age. A healthy well balanced diet with adequate protein (15l) will enhance 
well-being and reduce morbidity. Yet, many older people in poverty frequently eat 
food that is energy rich and nutrient poor or energy and nutrient poor. There have 
been several recent reviews of the nutritional needs of the older person (13, 16-19).  
 
In many frail older people, dehydration is a real issue that can cost lives. Thirst may 
decline with age, and this may be related to decline in endocrine and renal function 
(20). Medication (diuretics), which in adverse circumstances (hot weather, excessive 
fluid loss [diarrhoea]), may result in a shift of fluid balance and an increase in 
osmolalilty (21), resulting in delirium, falls and cardiac arrhythmias which could be 




Appetite is complex and will be influenced by endogenous (hormonal and 
neurological pathways), disease (eg cancer, infection and cardiorespiratory disease), 
mood (eg depression or phobias) and medication (eg metformin and cytotoxins; (22). 
Many frail old people will be on a multitude of medicines and may have several 
medical conditions. Untangling the contributory effects can therefore be difficult.  
Frail older people have a greater degree of non-specific satiation with food (23) and 
a reduction in hunger drive (24). The exact mechanism is uncertain but is a 
combination between the feedback from stomach stretch receptors and changes to 
gut hormone levels delaying gastric emptying (14) particularly neuropeptide Y 
(response to fasting attenuated), cholecystokinin (raised fivefold) and leptin (raised) 
(25). Studies have noted a reduction in taste and olfactory function with many foods 
tasting bland, resulting in a tendency for strong/pungent flavours with a high fat 
content (14).  Loss of fine-tuning of the appetite-energy balance loop has one benefit 
(24); when food supplements (eg drinks and snacks) are provided in order to boost 
energy intake (26) and given 90 minutes before a main meal, there is no diminution 
of energy intake from that meal. The net result is an increase in the daily energy 
intake. Constipation may also be the an aetiological factor leading to loss of appetite 
and can be difficult to treat Yue et al suggest a herbal formula that may be of use 




Between the ages of 40-75 years there is a 25% reduction in food and energy intake 
(28). Not only is intake reduced, utilisation is inefficient. The body is unable to 
respond to increased energy input after a period of illness and or starvation (14,29). 
Amino acid availability from a protein load is blunted, resulting in a 2% deficit in 
muscle synthesis from a 20g protein meal (30,31). This is exacerbated by many 
meals being protein poor. 
 
Any stored energy is not utilised efficiently, and given that physical activity may use 
up to 35% of energy expenditure (32), the inefficient use of energy may contribute to 
the slowing of the pace at which physical tasks are completed. Thus healthy women 
of 70 years of age will expend 20% more energy than younger women, when walking 





Frailty is the result of a decline in molecular, cellular and physiological systems 
(33,34), resulting in an impaired homeostatic reserve and reduced capacity to 
withstand physiological stress. The final underlying pathway is uncertain, but the 
inflammatory system is thought to be the common pathway (35,36) supported by the 
fact that both turmeric and melatonin (37,38) are reported to affect ageing/frailty via 
the immunoglobulin and cytokine systems. 
 
The clinical effects are demonstrated as an age-related cumulative physical decline, 
typified by weight loss (significant un-intentional weight loss with age often precedes 
significant disease; (39,40)). Also, weakness, exhaustion, reduced energy 
expenditure, slow gait speed and low physical activity are contributors (33,41,-43); 
Frailty describes the vulnerability of older people regarding health-related disability, 
dependency and the need for long-term care. Pre-frailty is typically defined as the 
transitional stage between the non-frail and frail state (44), where only one or two 
factors of frailty are present. Frailty and sarcopenia frequently occur together (33,41). 
There are several tools to grade the severity of frailty. In the UK, the most common 
are the Clinical Frailty Scale, used in secondary care (45) and the EFI, commonly 
used in primary care (46). 
 
Sarcopenia 
Sarcopenia has been defined as the age-related changes that occur in skeletal 
muscle influenced by hormonal, neurological, inflammatory, and dietary factors (25). 
Sarcopenia has been shown to have a negative impact on other systems increasing 
the risk of and associated with increased fragility fractures and lower bone density 
(47) and increased cognitive impairment (48). Neuromuscular activation is reduced 
in sarcopenia (49) and muscle tissue is replaced with fat and connective tissue (50). 
One key aspect of sarcopenia relates to the specific atrophy of type II muscle fibres 
during ageing - muscle fibres which are associated with strength, power and muscle 
mass (greater cross sectional area) (50,51), which is disproportionately greater than 
the loss of muscle mass (i.e. rate of loss with age) indicating involvement of other 
factors. Manini and Clark have termed this loss in strength and power with ageing 
‘dynapenia’ (49).  
 
The scale of muscle loss and strength, ranges from 15%, (50-60 years) to 30% (70-
80 years) and >50% in those >80 years (more so in males). However, this is not 
inevitable and can be reversed by an exercise programme and increased protein 





At the inception of Geriatric Medicine, the ‘giants’ or ‘syndromes’ identified were few 
(continence, cognitive decline, acute confusion, falls). In later years many more 
areas have been put forward, including frailty (54). All geriatric syndromes are 
associated with multiple aetiological factors and general decline with an increased 




Functional fitness represents the physical capacity that is needed to undertake 
normal everyday activities, independently and without the early onset of fatigue (55). 
Functional fitness is a composite of physical and mental health (56); death was 
associated with being less physically active (RR = 2.69) and self-rating of fair/poor 
on the global health score (RR = 2.13; 51).  Milanovic et al, compared young elderly 
(60-69years of age) and old elderly (70-80years of age) in a total of 1288 study 
participants (57). They found that physical activity (assessed using the International 
Physical Activity Questionnaire) and functional fitness (assessed using a ‘Seniors 
Fitness test’ back scratch, chair sit and reach, 8-foot up and go, chair stand up for 30 
seconds, arm curl, and 2-minute step test) was lower in the old frail group. 
  
Frailty and sarcopenia contribute to a decline in functional fitness (and an increase in 
all-cause mortality; (58)) and is a consequence of loss in strength, proprioception 
and power (59). This decline is exacerbated by the intervention of stressors 
(falls/trauma, infection, medication, infection) due to the precarious homeostatic state 
that frail patients seem to be in.  
Recovery from the stressor insult is frequently slow and incomplete, resulting in a 
lower functional fitness. Immobility (often enforced) is a great threat to functional 
fitness. In 1960, the US Public Health Service reported that disability from 
immobilization was one of 10 preventable health problems and argued that, with 
existing knowledge, such disability could be reduced by 50-75% (60). Illness, 
admission to hospital and bedrest will result in the beginning of functional decline by 
the second day and16% of patients who experienced functional decline during 
hospitalization died within three months of discharge (60).  
 
Intervention (Fig 1) 
Can the inevitable decline be prevented or reversed? Prevention is better than cure 
and one approach is to identify ‘at-risk’ people at the pre-frail stage. Then, a 
multimodal intervention is needed. A single approach, i.e. muscle training will 
probably improve strength but this may not improve functional ability. 
 
If the primary aetiology is the inflammatory pathway, then the use of antioxidants and 
anti-inflammatory agents (Tumeric, Melatonin, Ibuprofen) may be appropriate. 
Improving nutrition with fresh fruit (eg blueberries), vegetables and spices (eg 
turmeric; (37,38,61) may prevent the damage brought about by reactive oxygen 
species (free radicals).  
 
Environmental changes that are more conducive to socialisation and eating will 
improve calorie intake. Improving diary intake will support improved muscle function, 
increased skeletal mass and increased grip strength (62). A balanced diet (eg 
‘mediterranean diet’(63)) has been shown to improve physical and cognitive function, 
though the consensus would be that whole food is more beneficial and less harmful 
than individual components, even if they are reported as having anti-oxidant potential 
(35). 
 
Weight-bearing physical activity (e.g. walking and dance; (64,65) has been shown to 
improve outcome. The role of growth hormone, insulin and non-steroidal anti-
inflammatory (ibuprofen) medication is less certain and, although muscle mass may 
reduce falls, strength increases may not. There is a suggestion that proprioception 
may be a better approach than solely increased muscle strength and mass, which 
may be why dance has been shown to be effective in a number of studies. Also, 
some research suggests that resistance training needs to be incorporated into a 
programme of exercises that include flexibility and balance (see 
www.nhs.uk/exercises-for-older-people).  
However, there is uncertainty as to which form of resistance training is beneficial in 
curtailing sarcopenia and frailty. Different approaches have included conventional 
strength training, maximal strength training and high velocity training (51,66-68). The 
essential outcome of any exercise programme is a positive outcome on functional 
activities of daily living (walking, climbing stairs). Recent reviews appear to suggest 
that higher velocity training (68) may be more beneficial than high resistance (67) 
even in older people living in care homes (68). 
A systematic review of 62 studies involving progressive resistance training for older 
adults (n = 3674; 64) showed that, despite many trials being of poor quality, the 
overall trend was for a positive effect of progressive resistance training on strength 
and function (eg gait speed) (69). Indeed, in 2009, the Cochrane Database 
systematic review of 121 trials (n=6700) on the effects of progressive resistance 
training on physical function (70,71) found that it was associated with a small but 
significant improvement in physical ability and function, e.g. gait speed and sit-to-
stand, alongside significant improvements in strength, with no adverse effects. 
 
If the progress to frailty is not arrested, society (health and social) will be required to 
treat and support an ever increasing burden. Western medicine may have its limits 
and several article published in this edition look at osteoporosis (72), osteoathrits 




We all get older; we eat less and exercise less. Many of these changes are 
physiological and can result in ill-health. This seems to be because a decline in 
cellular systems results in a compromise in homeostasis and an inability of the 
individual to cope with external stress (trauma, infection, constipation, medication 
change). Frailty is the Geriatric Syndrome that encompasses this and is associated 
with high levels of morbidity and mortality. However, it may be possible to delay this 
decline. It may be possible to avoid repeated hospitalisation, by suitable intervention, 
involving multi-modal programmes that include modification and monitoring of diet, 
exercise and medication.  
 
Questions to be answered with respect to frailty include; What is the best pathway to 
healthy ageing such that frailty be prevented? Can frailty be reversed, especially to 
reduce hospitalisation rates? Certainly, growing evidence is suggesting that nutrition 
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